Equitable Holdings, Inc. Sellas Life Sciences Group, Inc. Transaction History
Equitable Holdings, Inc.
- $9.13 Billion
- Q2 2024
A detailed history of Equitable Holdings, Inc. transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Equitable Holdings, Inc. holds 210,000 shares of SLS stock, worth $247,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210,000
Previous 200,000
5.0%
Holding current value
$247,800
Previous $202,000
23.27%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SLS
# of Institutions
37Shares Held
4.38MCall Options Held
3.27MPut Options Held
56.3K-
Vanguard Group Inc Valley Forge, PA1.79MShares$2.11 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA517KShares$610,0690.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$507,8340.0% of portfolio
-
Empery Asset Management, LP New York, NY308KShares$363,9893.71% of portfolio
-
Opus Capital Group, LLC226KShares$266,7980.04% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24.3M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...